News for Repare Therapeutics Inc. (RPTX)

Cathie Wood's ARK Invest has made notable adjustments to its portfolio across several actively managed exchange-traded funds (ETFs), signaling a strategic

On Thursday, Cathie Wood-led Ark Invest made significant trades, most notably offloading ARK 21Shares Bitcoin ETF (BATS:ARKB) and pouring funds into the newly listed 3iQ Solana Staking ETF (SOLQ.U).

On Wednesday, Cathie Wood-led Ark Invest made significant trades, notably acquiring shares in Robinhood Markets Inc. (NASDAQ:HOOD), ARK 21Shares Bitcoin ETF (BATS:ARKB), and 3iQ S

On April 11th, 2025, Cathie Wood's Ark Invest sold shares in UiPath, Prime Medicine, and Repare Therapeutics, with notable gains and losses.

Ark Invest made major buys in Tempus AI and Coinbase on Thursday, as markets slid amid economic uncertainty and Trump's new 145% China tariffs.

On Friday, April 4, 2025, Cathie Wood-led Ark Invest made substantial trades involving several prominent companies including Coinbase Global Inc. COIN, Amazon.c...

On Thursday, April 3, 2025, Cathie Wood-led Ark Invest purchased Robinhood stock worth $1.39 million amid a broader market slump.

On Tuesday, April 1, 2025, Cathie Wood-led Ark Invest purchased $328,648 worth of Robinhood stock.

Repare Therapeutics names Steve Forte as CEO, announces updates on pivotal clinical trials with key data expected in 2025.

Cathie Wood-led Ark Invest made substantial trades, buying Robinhood and CoreWeave shares and selling Roblox, Genius Sports, Roku, and Spotify shares.

Cathie Wood-led Ark Invest made notable trades, buying IRDM, BEAM, PACB, ABSI and selling ILMN, RPTX, AMGN, VEEV.

Ark Invest's Cathie Wood-led funds made significant trades involving GitLab, Intellia, Prime Medicine, UiPath, Ibotta, Roblox, Repare Therapeutics, and CareDx.

Repare Therapeutics (RPTX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Repare Therapeutics Inc. (”œRepare” or the ”œCompany”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that the Compensation

On Thursday, March 6, 2025 Ark Invest made significant trades in Tempus AI and GitLab, increasing its tech and AI exposure after their earnings reports, while also adjusting positions in other stocks.

Repare Therapeutics Inc. (”œRepare” or the ”œCompany”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today reported financial results for

On December 31, 2024, a notable transaction took place involving Repare Therapeutics Inc (RPTX), a Canadian precision medicine oncology company. The transaction

Repare Therapeutics (RPTX) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Repare Therapeutics (RPTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.